OptimizeRx Corp
OPRX
Market Cap$238.22M
Close$
$-2.05
115.9% downside
Current Fair Value
115.9% downsideOvervalued by 115.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $238.22 Million |
|---|---|
| Enterprise Value | $229.15 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.1 |
| Beta | 1.33 |
| Outstanding Shares | 18,470,808 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -15.44 |
|---|---|
| PEG | 22.66 |
| Price to Sales | 2.58 |
| Price to Book Ratio | 2.15 |
| Enterprise Value to Revenue | 2.43 |
| Enterprise Value to EBIT | -13.58 |
| Enterprise Value to Net Income | -15 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.06 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About OptimizeRx Corp
OptimizeRx is a digital health company that provides communications solutions for life science companies, physicians and patients. Connecting over half of healthcare providers in the U.S. and millions of patients through a proprietary ne...